Clinical Trials Sponsored by Philip Blazar

Total 799 results

Philips Healthcare
Philips Medical Systems

Completed

Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids

Uterine Fibroids

Korea, Republic of, Netherlands, France, Germany
Philips Healthcare
Philips Medical Systems

Completed

Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner

Uterine Leiomyomas

Norway
Philip Morris Products S.A.

Recruiting

Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.

Smoking | Tobacco Use | COPD

United States, Bulgaria, Czechia, Germany, Japan, Romania, Slovakia, United Kingdom
Philip Morris Products S.A.

Completed

Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

Smoking | Inflammation | Oxidative Stress | Smoking Abstinence

Japan, Germany, Czechia, Greece
Philip Morris Products S.A.

Completed

Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence

Nicotine | Nicotine Vaping | Vaping

United Kingdom
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - Italy

Tobacco Use

Switzerland
Philip Morris Products S.A.

Active, not recruiting

Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)

Tobacco Use

Canada
Philip Morris Products S.A.

Completed

Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking.

Smoking | Abdominal Aortic Aneurysm | IQOS Use

Japan
Philip Morris Products S.A.

Completed

A Smoking Cessation Study to Understand the Biological and Functional Changes After One Year of Smoking Cessation (RIBESC)

Cigarette Smoking

United States, Poland, Germany, Japan, United Kingdom
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers

Smoking | Nicotine

United Kingdom
Philip Grant

Withdrawn

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) (ReNew)

HIV/AIDS | Osteopenia | HIV-1-infection

United States
Philip Morris Products S.A.

Completed

Product Use and Adaptation, Safety and Tolerability of P3P in Adult Healthy Smokers Switching to it

Pharmacokinetics

Russian Federation
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile of the CHTP 1.1 M

Smoking

Japan
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol).

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 Menthol (THS 2.2 Menthol)

Smoking

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.

Smoking

Poland
Philip Morris Products S.A.

Completed

European Exposure Study

Smoking

United Kingdom
Philip Morris Products S.A.

Completed

User Acceptability of a Nicotine Lactate Delivery System (P3L)

Smoking

United States
Philip Morris Products S.A.

Unknown

Japanese Post-Market Cohort Study

Smoking | Tobacco Product

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

Smoking

Japan
Philip Morris Products S.A.

Terminated

Cross-Sectional Survey on the Use of Tobacco Products - Germany

Tobacco Use

Switzerland
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG

Smoking, Tobacco

United Kingdom
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.

Smoking

Poland
Philip Morris Products S.A.

Completed

Effect of Switching From Cigarette Smoking to IQOS on Exercise Capacity

Smoking | Exercise Capacity

Germany
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting

Smoking

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement Setting

Smoking

Japan
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

Pharmacokinetics

Switzerland
Philip Morris Products S.A.

Completed

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

Vaping | Nicotine Absorption

United States
Philip Morris Products S.A.

Completed

Exploratory THS 2.1 Biomarkers of Exposure Study (ZRHX-EX-01)

Smoking

Poland
Philip Morris Products S.A.

Completed

Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety Study

Smoking

United Kingdom
Philip Morris Products S.A.

Completed

Smoking Research Study

Smoking | Non-smoking

United Kingdom
Philips Respironics

Completed

Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation

Healthy | Sleep Deprivation | Insufficient Sleep Syndrome

United States
Philips Respironics

Completed

A Study of the Effectiveness and Efficacy of the PowerSleep Device

Healthy | Sleep Deprivation | Insufficient Sleep Syndrome

United States
Philips Respironics

Completed

User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application

Sleep Disordered Breathing

United States
Philips Healthcare

Completed

Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging (EPISODE)

Heart Failure | Cardiac Disease | Cardiac Ischemia

France
Philips Respironics

Completed

A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD

COPD

United States
Philips Respironics

Completed

A Study to Determine Preferences Towards Interface Products

Sleep Disorder; Breathing-Related

United States
Philips Respironics

Completed

Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders

Sleep Disordered Breathing | Sleep Apnea, Central

United States
Philips Respironics

Terminated

Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device Compared to BiPAP S/T Device (SV3-ST)

Sleep Disordered Breathing

United States
Philips Respironics

Completed

CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence

Adherence

United States
Philips Respironics

Completed

Servo-Ventilation In-lab PSG Evaluation

Sleep Apnea Syndromes

United States
Philips Respironics

Completed

In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study

Snoring

United States
Philips Respironics

Completed

Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device (AUTOSV3)

Sleep Disordered Breathing | Sleep Apnea, Central

United States
Philips Respironics

Completed

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

Sleep Apnea

United States
Philips Respironics

Completed

Feasibility, Effectiveness and Efficacy of the PowerSleep Device

Sleep | Sleep Disorders Not Due to A Substance or Known Physiological Condition

United States
Philips Respironics

Withdrawn

Validation of Sleepware G3 Autoscoring Algorithm

Polysomnography Scoring
Philips Respironics

Completed

Alice PDx User/Validation Extended Trial

Sleep Apnea | Sleep-Disordered Breathing

United States
Philips Respironics

Completed

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

Obstructive Sleep Apnea | Cheyne-Stokes Respiration | Sleep Apnea Central

United States
Philips Healthcare

Completed

Preliminary Assessment of Added Diagnostic Value of Dual Energy CT Images Using Data Acquired on a Spectral Detector CT

Compare Image Quality Between SDCT and Conventional CT Images of Any Tissue Lesion, Determine Optimal Monochromatic Energy Level for a Coronary Artery Image

United States

3

Subscribe